Prospective Grant of Exclusive License: Terahertz Scanning Systems for Cancer Pathology, 59941-59942 [2012-24022]
Download as PDF
Federal Register / Vol. 77, No. 190 / Monday, October 1, 2012 / Notices
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: September 24, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: October 18, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Weiqun Li, MD, Scientific
Review Officer, National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Blvd., Ste. 710, Bethesda, MD
20892, (301) 594–5966, wli@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
[FR Doc. 2012–24003 Filed 9–28–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
59941
Dated: September 25, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24001 Filed 9–28–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Terahertz Scanning Systems
for Cancer Pathology
National Institutes of Health,
Public Health Service, HHS.
AGENCY:
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health (NIH), Department
of Health and Human Services (HHS), is
contemplating the grant of a worldwide
exclusive evaluation option license, to
practice the inventions embodied in:
SUMMARY:
HHS REF. NO. E–243–2010/0 ‘‘TETRAHERTZ SPATIAL LIGHT MODULATOR FOR COMPUTER-CONTROLLED ADAPTIVE NEAR
FIELD IMAGING OF BIOLOGICAL SYSTEMS’’
Territory
Filing date
61/425,007 ...............................................................
PCT/US2011/65734 .................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Patent application No.
US ..................................
Int’l ..................................
December 20, 2010 ................................................
December 19, 2011 ................................................
to Transformatix Technologies, Inc., a
company incorporated under the laws of
the State of California having its
headquarters in Davis, California. The
United States of America is the assignee
of the rights of the above inventions.
The contemplated exclusive license may
be granted in a field of use limited to
terahertz scanning systems for cancer
pathology. Upon the expiration or
termination of the exclusive evaluation
option license, Transformatix will have
the right to execute an exclusive patent
commercialization license which will
supersede and replace the exclusive
evaluation option license with no
greater field of use and territory than
granted in the evaluation license.
Only written comments and/or
applications for a license received by
the NIH Office of Technology Transfer
on or before October 16, 2012 will be
considered.
DATES:
Requests for a copy of the
patent application, inquiries, comments
ADDRESSES:
VerDate Mar<15>2010
16:48 Sep 28, 2012
Jkt 226001
and other materials relating to the
contemplated license should be directed
to: Michael A. Shmilovich, Esq., CLP,
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
5019; Facsimile: (301) 402–0220; Email:
shmilovm@mail.nih.gov. A signed
confidentiality nondisclosure agreement
will be required to receive copies of any
patent applications that have not been
published by the United States Patent
and Trademark Office or the World
Intellectual Property Organization.
SUPPLEMENTARY INFORMATION: The patent
applications (including any patents
issuing therefrom or claiming priority
thereto) intended for licensure describe
and claim a terahertz (THz) imaging
system that may overcome the
limitations of existing systems by using
the near-field effect at THz frequencies
to provide micron-scale spatial
resolution. Additionally, the THz
imaging system describes a sensor head
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Status
Expired.
Pending.
geometry that eliminates the
requirement to mechanically scan
samples, and also allows automatic
adjustment of image resolution and
transmitted power. The claimed system
has no moving components and is
therefore potentially suitable for
medical applications such as cancer
diagnosis of living subjects in hospital
settings. In one application, such as
‘‘one-cut’’ surgery, the compact sensor
head of the system may have the
capability of distinguishing healthy
cells from cancerous cells with micronscale spatial resolution by identifying a
skin cancer margin without the need for
laboratory work or the possibility of
additional surgery.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within fifteen (15) days from the date of
this published notice, NIH receives
written evidence and argument that
E:\FR\FM\01OCN1.SGM
01OCN1
59942
Federal Register / Vol. 77, No. 190 / Monday, October 1, 2012 / Notices
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: September 25, 2012.
Richard Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2012–24022 Filed 9–28–12; 8:45 am]
BILLING CODE 4140–01–P
Dated: September 25, 2012.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2012–24150 Filed 9–28–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[DHS Docket No. ICEB–2012–0004]
RIN 1653–ZA01
Extension of Employment
Authorization for Haitian F–1
Nonimmigrant Students Experiencing
Severe Economic Hardship as a Direct
Result of the January 12, 2010
Earthquake in Haiti
U.S. Immigration and Customs
Enforcement (ICE), DHS.
ACTION: Notice.
AGENCY:
This notice informs the public
of the extension of an earlier notice,
which suspended certain requirements
for F–1 nonimmigrant students whose
country of citizenship is Haiti and who
are experiencing severe economic
hardship as a direct result of the January
12, 2010 earthquake in Haiti. This
notice extends the effective date of that
notice.
DATES: This notice is effective October
1, 2012 and will remain in effect
through July 22, 2014.
FOR FURTHER INFORMATION CONTACT:
Louis Farrell, Director, Student and
Exchange Visitor Program; MS 5600,
U.S. Immigration and Customs
Enforcement; 500 12th Street SW.,
Washington, DC 20536–5600; (703) 603–
3400. This is not a toll-free number.
Program information can be found at
https://www.ice.gov/sevis/.
SUPPLEMENTARY INFORMATION:
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Listing of Members of the
National Institutes of Health’s Senior
Executive Service 2012 Performance
Review Board (PRB)
The National Institutes of Health
(NIH) announces the persons who will
serve on the National Institutes of
Health’s Senior Executive Service 2012
Performance Review Board. This action
is being taken in accordance with Title
5, U.S.C., Section 4314 (c) (4), which
requires that members of performance
review boards be appointed in a manner
to ensure consistency, stability, and
objectivity in performance appraisals
and requires that notice of the
appointment of an individual to serve as
a member be published in the Federal
Register.
The following persons will serve on
the NIH Performance Review Board,
which oversees the evaluation of
performance appraisals of NIH Senior
Executive Service (SES) members:
mstockstill on DSK4VPTVN1PROD with NOTICES
Colleen Barros, Chair; Courtney Billet;
John Czajkowski; Michael Gottesman;
Sally Rockey; Mona Rowe; Lawrence
Tabak.
For further information about the NIH
Performance Review Board, contact the
Office of Human Resources, Workforce
Relations Division, National Institutes of
Health, Building 31, Room B3C07,
Bethesda, Maryland 20892, telephone
301–402–9203 (not a toll-free number).
VerDate Mar<15>2010
16:48 Sep 28, 2012
Jkt 226001
What action is DHS taking under this
notice?
The Secretary of Homeland Security
is exercising her authority under 8 CFR
214.2(f)(9) to extend the suspension of
the applicability of certain requirements
governing on-campus and off-campus
employment for F–1 nonimmigrant
students whose country of citizenship is
Haiti and who are experiencing severe
economic hardship as a direct result of
the January 12, 2010 earthquake in
Haiti. See 75 FR 56120, September 15,
2010. The original notice was effective
from September 15, 2010 until July 22,
2011, with a subsequent notice
providing for an 18-month extension
from July 22, 2011 until January 22,
2013. See 76 FR 28997, May 19, 2011.
Effective with this publication,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
suspension of the requirements is
extended for an additional 18 months,
through July 22, 2014.
F–1 nonimmigrant students granted
employment authorization through the
notice will continue to be deemed to be
engaged in a ‘‘full course of study’’ for
the duration of their employment
authorization, provided they satisfy the
minimum course load requirement
described in 75 FR 56120. See 8 CFR
214.2(f)(6)(i)(F).
Who is covered under this action?
This notice applies exclusively to F–
1 nonimmigrant students whose country
of citizenship is Haiti and who were
lawfully present in the United States in
F–1 nonimmigrant status on January 12,
2010 under section 101(a)(15)(F)(i) of
the Immigration and Nationality Act
(INA), 8 U.S.C. 1101(a)(15)(F)(i), and (1)
are enrolled in an institution that is
Student and Exchange Visitor Program
(SEVP)-certified for enrollment of F–1
students, (2) are currently maintaining
F–1 status, and (3) are experiencing
severe economic hardship as a direct
result of the January 12, 2010
earthquake in Haiti.
This notice applies both to
undergraduate and graduate students, as
well as elementary school, middle
school, and high school students. The
notice, however, applies differently to
elementary school, middle school, and
high school students (see the discussion
published in 75 FR 56121 in the
question, ‘‘Does this notice apply to
elementary school, middle school, and
high school students in F–1 status?’’).
F–1 students covered by this notice
who transfer to other academic
institutions that are SEVP-certified for
enrollment of F–1 students remain
eligible for the relief provided by means
of this notice.
Why is DHS taking this action?
The Department of Homeland
Security (DHS) took action to provide
temporary relief to F–1 nonimmigrant
students whose country of citizenship is
Haiti and experienced severe economic
hardship as a result of the January 12,
2010 earthquake. See 75 FR 56120. It
enabled these F–1 students to obtain
employment authorization, work an
increased number of hours while school
was in session, and reduce their course
load, while continuing to maintain their
F–1 student status.
Haiti continues to struggle, with many
people still displaced as a result of the
earthquake. As Haiti rebuilds, the
country continues to experience
significant difficulties in recovering. F–
1 nonimmigrant students whose country
of citizenship is Haiti may depend on
E:\FR\FM\01OCN1.SGM
01OCN1
Agencies
[Federal Register Volume 77, Number 190 (Monday, October 1, 2012)]
[Notices]
[Pages 59941-59942]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24022]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive License: Terahertz Scanning
Systems for Cancer Pathology
AGENCY: National Institutes of Health, Public Health Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH),
Department of Health and Human Services (HHS), is contemplating the
grant of a worldwide exclusive evaluation option license, to practice
the inventions embodied in:
HHS Ref. No. E-243-2010/0 ``Tetrahertz Spatial Light Modulator for Computer-Controlled Adaptive Near Field
Imaging of Biological Systems''
----------------------------------------------------------------------------------------------------------------
Patent application No. Territory Filing date Status
----------------------------------------------------------------------------------------------------------------
61/425,007........................... US...................... December 20, 2010....... Expired.
PCT/US2011/65734..................... Int'l................... December 19, 2011....... Pending.
----------------------------------------------------------------------------------------------------------------
to Transformatix Technologies, Inc., a company incorporated under the
laws of the State of California having its headquarters in Davis,
California. The United States of America is the assignee of the rights
of the above inventions. The contemplated exclusive license may be
granted in a field of use limited to terahertz scanning systems for
cancer pathology. Upon the expiration or termination of the exclusive
evaluation option license, Transformatix will have the right to execute
an exclusive patent commercialization license which will supersede and
replace the exclusive evaluation option license with no greater field
of use and territory than granted in the evaluation license.
DATES: Only written comments and/or applications for a license received
by the NIH Office of Technology Transfer on or before October 16, 2012
will be considered.
ADDRESSES: Requests for a copy of the patent application, inquiries,
comments and other materials relating to the contemplated license
should be directed to: Michael A. Shmilovich, Esq., CLP, Office of
Technology Transfer, National Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD 20852-3804; Telephone: (301) 435-
5019; Facsimile: (301) 402-0220; Email: shmilovm@mail.nih.gov. A signed
confidentiality nondisclosure agreement will be required to receive
copies of any patent applications that have not been published by the
United States Patent and Trademark Office or the World Intellectual
Property Organization.
SUPPLEMENTARY INFORMATION: The patent applications (including any
patents issuing therefrom or claiming priority thereto) intended for
licensure describe and claim a terahertz (THz) imaging system that may
overcome the limitations of existing systems by using the near-field
effect at THz frequencies to provide micron-scale spatial resolution.
Additionally, the THz imaging system describes a sensor head geometry
that eliminates the requirement to mechanically scan samples, and also
allows automatic adjustment of image resolution and transmitted power.
The claimed system has no moving components and is therefore
potentially suitable for medical applications such as cancer diagnosis
of living subjects in hospital settings. In one application, such as
``one-cut'' surgery, the compact sensor head of the system may have the
capability of distinguishing healthy cells from cancerous cells with
micron-scale spatial resolution by identifying a skin cancer margin
without the need for laboratory work or the possibility of additional
surgery.
The prospective exclusive license will be royalty bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
The prospective exclusive license may be granted unless, within fifteen
(15) days from the date of this published notice, NIH receives written
evidence and argument that
[[Page 59942]]
establishes that the grant of the license would not be consistent with
the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Properly filed competing applications for a license filed in
response to this notice will be treated as objections to the
contemplated license. Comments and objections submitted in response to
this notice will not be made available for public inspection, and, to
the extent permitted by law, will not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: September 25, 2012.
Richard Rodriguez,
Director, Division of Technology Development and Transfer, Office of
Technology Transfer, National Institutes of Health.
[FR Doc. 2012-24022 Filed 9-28-12; 8:45 am]
BILLING CODE 4140-01-P